105.0548
123.445
1
Suitability:
This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.
We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in multi cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.
But if you do invest, you must do so only through the SIP route. Click here to read a primer on SIP investing.
Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.
Taxability of earnings:
Capital gains
Dividends
Please wait...
Please wait...
| YTD | 1 Month | 3 Months | 1 Years | 3 Years | 5 Years | 10 Years | |
|---|---|---|---|---|---|---|---|
| Fund | -1.15 | 2.83 | 4.70 | -1.21 | -4.86 | -0.33 | 12.78 |
| S&P BSE Healthcare TRI | -3.19 | 3.27 | 2.76 | -2.71 | -4.20 | -1.61 | 11.25 |
| Equity: Sectoral-Pharma | 2.73 | 3.18 | 4.34 | 3.02 | -1.13 | 1.09 | 12.38 |
| Rank within category | 7 | 8 | 5 | 7 | 4 | 3 | 2 |
| Number of funds in category | 7 | 9 | 9 | 7 | 4 | 3 | 3 |
As on 13-Dec-2019
| Best (Period) | Worst (Period) | |
|---|---|---|
| Month | 35.97 (05-May-2009 - 04-Jun-2009) | -33.77 (01-Oct-2008 - 31-Oct-2008) |
| Quarter | 74.69 (12-Mar-2009 - 11-Jun-2009) | -44.39 (02-Sep-2008 - 02-Dec-2008) |
| Year | 162.88 (07-May-2003 - 06-May-2004) | -51.81 (12-Mar-2008 - 12-Mar-2009) |
| Mean | Std Dev | Sharpe | Sortino | Beta | Alpha | |
|---|---|---|---|---|---|---|
| Fund | -3.67 | 16.65 | -0.57 | -1.02 | 0.90 | -1.84 |
| S&P BSE Healthcare TRI | -2.70 | 17.56 | -0.48 | -0.84 | -- | -- |
| Equity: Sectoral-Pharma | -0.11 | 15.75 | -0.37 | -0.62 | 0.85 | 1.35 |
| Rank within category | 4 | 4 | 4 | 4 | 4 | 4 |
| Number of funds in category | 4 | 4 | 4 | 4 | 4 | 4 |
The Risk Measures have been calculated using calendar month returns for the last three years.
As on 30-Nov-2019
Please wait...
| Number of Stocks | 21 |
| Top 10 Stocks (%) | 70.38 |
| Top 5 Stocks (%) | 46.19 |
| Top 3 Sectors (%) | 96.09 |
| Portfolio P/B Ratio | 3.20 |
| Portfolio P/E Ratio | 24.67 |
| Fund | Benchmark | Category* | |
|---|---|---|---|
| Average Mkt Cap (Rs Cr) | 20,234 | 23,516 | |
| Giant (%) | -- | -- | |
| Large (%) | 35.33 | 35.74 | |
| Mid (%) | 50.56 | 51.60 | |
| Small (%) | 14.12 | 12.65 | |
| Tiny (%) | -- | -- |
Please wait...
| Company | Sector | P/E | 3Y High | 3Y Low | % Assets | |
|---|---|---|---|---|---|---|
|
Sun Pharmaceutical Inds. | Healthcare | 24.31 | 15.93 | 0.00 | 11.91 |
|
Cipla | Healthcare | 22.56 | 10.24 | 2.05 | 9.89 |
|
|
Divi's Laboratories | Healthcare | 37.89 | 11.64 | 2.41 | 9.46 |
|
Lupin | Healthcare | 109.13 | 10.14 | 0.00 | 8.48 |
|
|
Alkem Laboratories | Healthcare | 26.76 | 6.59 | 3.12 | 6.45 |
|
|
Abbott India | Healthcare | 52.46 | 5.33 | 0.00 | 5.33 |
|
|
Torrent Pharmaceuticals | Healthcare | 56.99 | 6.79 | 3.89 | 5.03 |
|
|
Strides Pharma Science | Healthcare | 6.77 | 10.20 | 4.39 | 4.93 |
|
|
Alembic Pharmaceuticals | Healthcare | 15.65 | 4.70 | 0.00 | 4.68 |
|
|
Ajanta Pharma | Healthcare | 22.12 | 4.58 | 0.00 | 4.22 |
|
|
Sanofi India | Healthcare | 40.54 | 3.75 | 2.35 | 3.75 |
|
|
Pfizer | Healthcare | 38.99 | 3.51 | 0.00 | 3.51 |
|
|
Aster DM Healthcare | Healthcare | 24.35 | 3.99 | 0.00 | 3.40 |
|
|
Ipca Laboratories | Healthcare | 23.96 | 3.14 | 0.00 | 3.03 |
|
|
Gufic Biosciences | Healthcare | 20.97 | 5.17 | 0.00 | 2.72 |
|
|
Dr. Reddy's Lab | Healthcare | 17.12 | 10.80 | 0.00 | 2.47 |
|
|
Alembic | Healthcare | 29.75 | 2.49 | 0.00 | 2.24 |
|
|
Sequent Scientific | Healthcare | 25.63 | 3.97 | 1.36 | 2.17 |
|
|
Solara Active Pharma Sciences | Healthcare | 10.54 | 1.52 | 0.00 | 1.42 |
|
|
Shreno | Construction | 0.61 | 0.00 | 0.61 | |
|
Natco Pharma | Healthcare | 19.53 | 5.88 | 0.00 | 0.39 |
Indicates an increase or decrease or no change in holding since last portfolio
Indicates a new holding since last portfolio
As on 30-Nov-2019
— Tanmaya Desai since 27-Jun-2011
Education: Mr. Desai is a B.E. (Electronics), MBA (Finance) and CFA (Level III).
Experience: Prior to joining SBI Mutual Fund he has worked with D.J. Sanghvi College of Engineering and Patni Computer Systems Ltd.
Interviews:
Personal finance advice and mutual fund ideas delivered to your inbox every Monday
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
| Minimum Investment (₹) | 5,000 |
| Minimum Addl Investment (₹) | 1,000 |
| Minimum SIP Investment (₹) | 500 |
| Minimum No of Cheques | 12 |
| Minimum Withdrawal (₹) | 500 |
| Minimum Balance (₹) | 1,000 |
| Exit Load | 0.5% for redemption within 15 days |
| Fund House: | SBI Mutual Fund |
| Launch Date: | 05-Jul-1999 |
| Benchmark: | S&P BSE Healthcare TRI |
| Riskometer: | High |
| Type: | Open-ended |
| Assets: | ₹ 944 Cr (As on 30-Nov-2019) |
| Expense: | 2.37% (As on 31-Oct-2019) |
| Risk Grade: | -- |
| Return Grade: | -- |
| Turnover: | -- |
Interview - 12-Mar-2019
Fund News - 13-Apr-2018
Fund News - 12-Mar-2018
Interview - 16-Aug-2016
Fund News - 14-Jul-2016
AMC: SBI Funds Management Ltd
Address: 9th Floor-Crescenzo, C-38 & 39- G Block, Bandra-Kurla Complex, Bandra (East) Mumbai - 400051
Phone: 022-61793000 / 1800-425-5425
Fax: 022-22189663
Email: [email protected]
Website: www.sbimf.com
Registrar & Transfer Agent: Computer Age Management Services Ltd.
Address: 7th Floor, Tower II, Rayala Towers, 158, Anna Salai, Chennai - 600002
Phone: 1800-3010-6767 / 1800-419-7676
Fax: 044-30407101
Email: [email protected]
Website: www.camsonline.com
Friday, 20-Dec-2019
12:30 PM - 01:00 PM